FDWGX
Price
$10.80
Change
-$0.08 (-0.74%)
Updated
Nov 13 closing price
RNWEX
Price
$80.75
Change
-$0.65 (-0.80%)
Updated
Nov 13 closing price
Ad is loading...

FDWGX vs RNWEX

Header iconFDWGX vs RNWEX Comparison
Open Charts FDWGX vs RNWEXBanner chart's image
American Funds Dvlpg Wld Gr&Inc F3
Price$10.80
Change-$0.08 (-0.74%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$80.75
Change-$0.65 (-0.80%)
VolumeN/A
CapitalizationN/A
FDWGX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDWGX vs. RNWEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDWGX is a Sell and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 62.3B vs. FDWGX (1.86B). FDWGX pays higher dividends than RNWEX: FDWGX (2.01) vs RNWEX (1.24). FDWGX was incepted earlier than RNWEX: FDWGX (8 years) vs RNWEX (22 years). FDWGX is a more actively managed with annual turnover of: 37.00 vs. RNWEX (32.00). RNWEX has a lower initial minimum investment than FDWGX: RNWEX (250) vs FDWGX (1000000). RNWEX annual gain was more profitable for investors over the last year : 13.19 vs. FDWGX (11.82). RNWEX return over 5 years is better than : 17.93 vs. FDWGX (5.70).
FDWGXRNWEXFDWGX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD5.9668.38971%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B62.3B3%
Annual Yield % from dividends2.011.24162%
Returns for 1 year11.8213.1990%
Returns for 3 years-14.58-13.68107%
Returns for 5 years5.7017.9332%
Returns for 10 yearsN/A41.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DORM137.85-0.15
-0.11%
Dorman Products
TEVA16.94-0.17
-0.99%
Teva Pharmaceutical Industries Limited
CAPR16.91-1.19
-6.57%
Capricor Therapeutics
GEVO1.42-0.22
-13.41%
Gevo
OLB2.01-0.40
-16.46%
OLB Group Inc. (The)